What is the analyst consensus rating for BMRN?

The analyst consensus rating for BMRN is "Buy" based on 21 analyst recommendations.

What is the average price target for BMRN?

The average 12-month price target for BMRN is $88.89, representing an upside of 60.2% from the current price of $55.50.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

BioMarin Pharmaceutical Inc. (BMRN) Forecast: Analyst Ratings & Targets

Latest BMRN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Mar 11, 2026	Geoff Meacham	BofA Securities	Maintains	Strong Buy	$97.00 → $85.00 -12.00 (-12.4%)
Mar 4, 2026	Eliana Merle	Barclays	Maintains	Buy	$80.00 → $105.00 +25.00 (31.3%)
Mar 2, 2026	Ilya Zubkov	Freedom Broker	Maintains	Strong Buy	$100.00 → $105.00 +5.00 (5.0%)
Mar 2, 2026	Mitchell S. Kapoor	HC Wainwright	Reiterates	Hold	$55.00 → $55.00 +0.00 (0.0%)
Feb 26, 2026	Whitney Ijem	Canaccord Genuity	Maintains	Strong Buy	$98.00 → $104.00 +6.00 (6.1%)
Feb 25, 2026	PerPlexity Biotechnology	TipRanks - PerPlexity	Reiterates	Buy	$74.00 → $70.00 -4.00 (-5.4%)
Feb 25, 2026	Anthropic Biotechnology	TipRanks - Anthropic	Reiterates	Buy	$71.00 → $69.00 -2.00 (-2.8%)
Feb 25, 2026	OpenAI Biotechnology	TipRanks - OpenAI	Reiterates	Buy	$72.00 → $70.00 -2.00 (-2.8%)
Feb 25, 2026	Debjit Chattopadhyay	Guggenheim	Maintains	Strong Buy	$106.00 → $86.00 -20.00 (-18.9%)
Feb 25, 2026	Mitchell S. Kapoor	HC Wainwright	Maintains	Hold	$60.00 → $55.00 -5.00 (-8.3%)
Feb 25, 2026	William Pickering	Bernstein	Maintains	Buy	$90.00 → $94.00 +4.00 (4.4%)
Feb 24, 2026	Yun Zhong	Wedbush	Reiterates	Buy	$94.00
Feb 24, 2026	Sami Corwin	William Blair	Maintains	Hold	-
Feb 24, 2026	William Pickering	Bernstein	Initiates Coverage	Buy	$90.00 → $94.00 +4.00 (4.4%)
Feb 24, 2026	Phil Nadeau	TD Cowen	Maintains	Buy	$120.00
Feb 24, 2026	Leland Gershell	Oppenheimer	Maintains	Buy	$98.00 → $95.00 -3.00 (-3.1%)
Feb 24, 2026	Cory Kasimov	Evercore ISI Group	Maintains	Buy	$110.00
Feb 23, 2026	Luca Issi	RBC Capital	Maintains	Hold	$66.00
Feb 18, 2026	Mohit Bansal	Wells Fargo	Maintains	Buy	$70.00 → $75.00 +5.00 (7.1%)
Feb 12, 2026	Akash Tewari	Jefferies	Maintains	Buy	$113.00
Feb 6, 2026	Allison Bratzel	Piper Sandler	Maintains	Buy	$122.00 → $84.00 -38.00 (-31.1%)
Feb 1, 2026	Bret Jensen	TheStreet.com	Initiates Coverage	Buy	-
Jan 30, 2026	PerPlexity Biotechnology	TipRanks - PerPlexity	Reiterates	Buy	$64.00 → $63.00 -1.00 (-1.6%)
Jan 30, 2026	OpenAI Biotechnology	TipRanks - OpenAI	Reiterates	Buy	$62.00 → $63.00 +1.00 (1.6%)
Jan 27, 2026	Eliana Merle	Barclays	Maintains	Buy	$80.00
Jan 20, 2026	Whitney Ijem	Canaccord Genuity	Upgrades	Strong Buy	$84.00 → $98.00 +14.00 (16.7%)
Jan 15, 2026	Kinjel Shah	Zacks Equity Research	Initiates Coverage	Buy	-
Jan 13, 2026	Yun Zhong	Wedbush	Maintains	Buy	$94.00
Jan 13, 2026	Sami Corwin	William Blair	Maintains	Hold	-
Jan 13, 2026	Cory Kasimov	Evercore ISI Group	Maintains	Buy	$110.00
Jan 12, 2026	Phil Nadeau	TD Cowen	Maintains	Buy	$120.00
Jan 8, 2026	Luca Issi	RBC Capital	Maintains	Hold	$66.00

Geoff Meacham

BofA Securities

Strong BuyMaintains

$97.00 → $85.00

Mar 11

Eliana Merle

Barclays

BuyMaintains

$80.00 → $105.00

Mar 4

Ilya Zubkov

Freedom Broker

Strong BuyMaintains

$100.00 → $105.00

Mar 2

Mitchell S. Kapoor

HC Wainwright

HoldReiterates

$55.00 → $55.00

Mar 2

Whitney Ijem

Canaccord Genuity

Strong BuyMaintains

$98.00 → $104.00

Feb 26

PerPlexity Biotechnology

TipRanks - PerPlexity

BuyReiterates

$74.00 → $70.00

Feb 25

Anthropic Biotechnology

TipRanks - Anthropic

BuyReiterates

$71.00 → $69.00

Feb 25

OpenAI Biotechnology

TipRanks - OpenAI

BuyReiterates

$72.00 → $70.00

Feb 25

Debjit Chattopadhyay

Guggenheim

Strong BuyMaintains

$106.00 → $86.00

Feb 25

Mitchell S. Kapoor

HC Wainwright

HoldMaintains

$60.00 → $55.00

Feb 25

William Pickering

Bernstein

BuyMaintains

$90.00 → $94.00

Feb 25

Yun Zhong

Wedbush

BuyReiterates

$94.00

Feb 24

Sami Corwin

William Blair

HoldMaintains

Feb 24

William Pickering

Bernstein

BuyInitiates Coverage

$90.00 → $94.00

Feb 24

Phil Nadeau

TD Cowen

BuyMaintains

$120.00

Feb 24

Leland Gershell

Oppenheimer

BuyMaintains

$98.00 → $95.00

Feb 24

Cory Kasimov

Evercore ISI Group

BuyMaintains

$110.00

Feb 24

Luca Issi

RBC Capital

HoldMaintains

$66.00

Feb 23

Mohit Bansal

Wells Fargo

BuyMaintains

$70.00 → $75.00

Feb 18

Akash Tewari

Jefferies

BuyMaintains

$113.00

Feb 12

Allison Bratzel

Piper Sandler

BuyMaintains

$122.00 → $84.00

Feb 6

Bret Jensen

TheStreet.com

BuyInitiates Coverage

Feb 1

PerPlexity Biotechnology

TipRanks - PerPlexity

BuyReiterates

$64.00 → $63.00

Jan 30

OpenAI Biotechnology

TipRanks - OpenAI

BuyReiterates

$62.00 → $63.00

Jan 30

Eliana Merle

Barclays

BuyMaintains

$80.00

Jan 27

Whitney Ijem

Canaccord Genuity

Strong BuyUpgrades

$84.00 → $98.00

Jan 20

Kinjel Shah

Zacks Equity Research

BuyInitiates Coverage

Jan 15

Yun Zhong

Wedbush

BuyMaintains

$94.00

Jan 13

Sami Corwin

William Blair

HoldMaintains

Jan 13

Cory Kasimov

Evercore ISI Group

BuyMaintains

$110.00

Jan 13

Phil Nadeau

TD Cowen

BuyMaintains

$120.00

Jan 12

Luca Issi

RBC Capital

HoldMaintains

$66.00

Jan 8

BioMarin Pharmaceutical Inc. (BMRN) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest BMRN Analyst Ratings & Recommendations

Frequently Asked Questions